ACADIA Pharmaceuticals (Nasdaq: ACAD) is higher today after the company announced that they will continue testing pimavanserin in Parkinson's, despite ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE